NCT06877299View on ClinicalTrials.gov

Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB Non-small Cell Lung Cancer

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 10, 2025

Primary Completion Date

July 1, 2027

Study Completion Date

January 1, 2028

Conditions
Lung CancerNon-small Cell Lung Cancer
Interventions
DRUG

Low-Dose Radiation(LDRT) + Stereotactic body radiotherapy (SBRT)

Low-Dose Radiation(LDRT) + Stereotactic body radiotherapy (SBRT)

Trial Locations (1)

610041

West China Hospital of Sichuan University, Chengdu

All Listed Sponsors
lead

Sichuan University

OTHER